# Microbially produced bile acids are associated with increased IgG autoantibodies and poorer mental wellbeing in fibromyalgia

**Authors:** Jenny E. Jakobsson, Henrik Carlsson, Ida Erngren, Joana Menezes, Emerson Krock, Matthew A. Hunt, Jeanette Tour Sohlin, Asma Al-Grety, Katalin Sandor, Eva Kosek, Camilla I. Svensson, Kim Kultima

PMC · DOI: 10.1038/s41598-026-40781-3 · Scientific Reports · 2026-02-24

## TL;DR

This study finds that fibromyalgia patients have higher levels of certain gut-produced bile acids linked to worse mental health and increased autoantibodies.

## Contribution

The study identifies a novel link between microbially produced bile acids, autoantibodies, and mental wellbeing in fibromyalgia.

## Key findings

- FM subjects had significantly higher levels of non-conjugated secondary bile acids compared to healthy controls.
- Total bile acid levels were elevated in FM patients with high anti-SGC IgG levels.
- Specific bile acid concentrations correlated with increased disease severity and poorer mental well-being.

## Abstract

Fibromyalgia (FM) is a disease primarily associated with chronic widespread pain, but other common symptoms are anxiety and depression. We previously proposed that autoimmunity contributes to FM based on findings of increased immunoglobulin G binding to satellite glial cells (anti-SGC IgG) in FM subjects compared to healthy controls (HC). Emerging research suggests that an altered gut microbiota composition is connected to psychological symptoms in FM. Gut microbiota can produce or alter bile acids (BAs) and short-chain fatty acids (SCFAs), which have important immune and inflammatory functions. Here, we investigate alterations in BA and SCFA concentrations in FM subjects compared to HC and potential associations with FM symptoms and anti-SGC IgG levels. Bile acids and SCFAs were quantified using liquid chromatography coupled with high-resolution mass spectrometry and anti-SGC IgG levels were assessed with immunocytochemistry. The correlations between FM symptoms, anti-SGC IgG levels, and serum concentrations of 24 BAs and 11 SCFAs in 35 FM subjects and 32 matched HC were examined. Fibromyalgia subjects had significantly higher levels of non-conjugated microbially produced (secondary) BAs compared to HC. Additionally, total BA levels were significantly elevated in FM subjects with high, compared to those with low, anti-SGC IgG levels. Concentrations of specific BAs were associated with increased disease severity and poorer mental well-being. These results revealed increased levels of non-conjugated secondary BAs in FM subjects compared to HC. The strong association between BAs, anti-SGC IgG levels, and mental well-being may help elucidate the importance of BAs in the psychological symptoms of FM.

The online version contains supplementary material available at 10.1038/s41598-026-40781-3.

## Linked entities

- **Diseases:** fibromyalgia (MONDO:0005546), anxiety (MONDO:0005618), depression (MONDO:0002050)

## Full-text entities

- **Genes:** Trpv1 (transient receptor potential cation channel, subfamily V, member 1) [NCBI Gene 193034] {aka OTRPC1, TRPV1alpha, TRPV1beta, VR-1, Vr1}, Srgn (serglycin) [NCBI Gene 19073] {aka Prg, Prg1, Sgc}, SGCB (sarcoglycan beta) [NCBI Gene 6443] {aka A3b, LGMD2E, LGMDR4, SGC}, Nr1h4 (nuclear receptor subfamily 1, group H, member 4) [NCBI Gene 20186] {aka Fxr, HRR1, RIP14, Rxrip14}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, NR1H4 (nuclear receptor subfamily 1 group H member 4) [NCBI Gene 9971] {aka BAR, FXR, HRR-1, HRR1, PFIC5, RIP14}, GPBAR1 (G protein-coupled bile acid receptor 1) [NCBI Gene 151306] {aka BG37, GPCR19, GPR131, M-BAR, TGR5}, Gpbar1 (G protein-coupled bile acid receptor 1) [NCBI Gene 227289] {aka BG37, GPCR, GPR131, M-BAR, TGR5}
- **Diseases:** Pain (MESH:D010146), disturbed sleep (MESH:D012893), HC (MESH:D000067329), gastrointestinal symptoms (MESH:D012817), chronic inflammation (MESH:D007249), Anxiety (MESH:D001007), diabetes (MESH:D003920), substance abuse (MESH:D019966), psychiatric disorders (MESH:D001523), overweight (MESH:D050177), BAD (MESH:D003967), fatigue (MESH:D005221), autoimmune conditions (MESH:D001327), mood disorders (MESH:D019964), MDD (MESH:D003865), hypertension (MESH:D006973), gastrointestinal disorders (MESH:D005767), FM (MESH:D005356), type 1 diabetes (MESH:D003922), Parkinsonism (MESH:D010302), visceral hypersensitivity (MESH:D004342), neuropathic pain (MESH:D009437), IBD (MESH:D015212), chronic pain (MESH:D059350), Depression (MESH:D003866), IBS (MESH:D043183), cognitive dysfunction (MESH:D003072), autoimmune hepatitis (MESH:D019693), multiple sclerosis (MESH:D009103)
- **Chemicals:** 2-methylbutyric acid (MESH:C019475), formic acid (MESH:C030544), methanol (MESH:D000432), DCA (MESH:D003840), 3-hydroxybutyric acid (MESH:D020155), 3-nitrophenylhydrazine (MESH:C523491), CA (MESH:D019826), isobutyric acid (MESH:C020380), propionic acid (MESH:C029658), isoflurane (MESH:D007530), leucine (MESH:D007930), H2O (MESH:D014867), 23-nordeoxycholic acid (MESH:C033582), Gly (MESH:D005998), cholesterol (MESH:D002784), Isovaleric acid (MESH:C008216), acetic acid (MESH:D019342), isopropanol (MESH:D019840), caproic acid (MESH:C037652), BA (MESH:D001647), valeric acid (MESH:C038780), EDC (-), lithocholic acid (MESH:D008095), CDCA (MESH:D002635), amino acid (MESH:D000596), hyodeoxycholic acid (MESH:C010471), ammonium acetate (MESH:C018824), lipid (MESH:D008055), glutathione (MESH:D005978), butyric acid (MESH:D020148), UDCA (MESH:D014580), glutamine (MESH:D005973), taurine (MESH:D013654), 2-hydroxybutyric acid (MESH:C031570), SCFA (MESH:D005232), HCA (MESH:C004821)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], gut metagenome (species) [taxon 749906]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12949243/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12949243/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12949243/full.md

---
Source: https://tomesphere.com/paper/PMC12949243